Activation of natriuretic peptide receptor-C attenuates the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats: Implication of Giα protein

Journal of Molecular and Cellular Cardiology

Volumn 44, Issue 2, 2008, Pages 336-344

  Saha, Soumya ^a   Li, Yuan ^a   Lappas, Georgios ^a   Anand Srivastava, Madhu B ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

G protein; NADPH oxidase; NPR C; Oxidative stress; Spontaneously hypertensive rats; Vascular smooth muscle cells

Indexed keywords

INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; NATRIURETIC PEPTIDE RECEPTOR C; NATRIURETIC PEPTIDE RECEPTOR C 2; NATRIURETIC PEPTIDE RECEPTOR C 3; PROTEIN P22; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; ATRIAL NATRIURETIC FACTOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; ONIUM COMPOUNDS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PERTUSSIS TOXIN; PROTEIN SUBUNITS; RATS; RATS, INBRED SHR; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SUPEROXIDES; TIME FACTORS;

RATTUS;

EID: 39149096849     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.11.003     Document Type: Article

References (37)

1. Brenner B.M., Ballermann B.J., Gunning M.E., and Zeidel M.L. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70 (1990) 665-699
2. Sudoh T., Kangawa K., Minamino N., and Matsuo H. A new natriuretic peptide in porcine brain. Nature 332 (1988) 78-81
3. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
4. Yandle T.G. Biochemistry of natriuretic peptides. J Intern Med 235 (1994) 561-576
5. Anand-Srivastava M.B., and Trachte G.J. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 45 (1993) 455-497
6. Anand-Srivastava M.B. Natriuretic peptide receptor-C signaling and regulation. Peptides 26 (2005) 1044-1059
7. Chinkers M., Garbers D.L., Chang M.S., Lowe D.G., Chin H.M., Goeddel D.V., et al. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338 (1989) 78-83
8. Chang M.S., Lowe D.G., Lewis M., Hellmiss R., Chen E., and Goeddel D.V. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 341 (1989) 68-72
9. Schulz S., Singh S., Bellet R.A., Singh G., Tubb D.J., Chin H., et al. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 58 (1989) 1155-1162
10. Anand-Srivastava M.B., Srivastava A.K., and Cantin M. Pertussis toxin attenuates atrial natriuretic factor-mediated inhibition of adenylate cyclase. Involvement of inhibitory guanine nucleotide regulatory protein. J Biol Chem 262 (1987) 4931-4934
11. Koller K.J., Lowe D.G., Bennett G.L., Minamino N., Kangawa K., Matsuo H., et al. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252 (1991) 120-123
12. Brown J., and Chen Q. Regional expression of natriuretic peptide receptors during the formation of arterial neointima in the rabbit. Circ Res 77 (1995) 906-918
13. Woodard G.E., Li X., and Rosado J.A. Water deprivation enhances the inhibitory effect of natriuretic peptides on cAMP synthesis in rat renal glomeruli. Am J Physiol Renal Physiol 287 (2004) F418-F426
14. Chen H.H., and Burnett Jr. J.C. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol 32 (1998) S22-S28
15. Anand-Srivastava M.B., Sairam M.R., and Cantin M. Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system. J Biol Chem 265 (1990) 8566-8572
16. Hirata M., Chang C.H., and Murad F. Stimulatory effects of atrial natriuretic factor on phosphoinositide hydrolysis in cultured bovine aortic smooth muscle cells. Biochim Biophys Acta 1010 (1989) 346-351
17. Anand-Srivastava M.B. Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats. Relationship to adenylate cyclase inhibition. Biochem J 288 (1992) 79-85
18. Anand-Srivastava M.B., de Champlain J., and Thibault C. DOCA-salt hypertensive rat hearts exhibit altered expression of G-proteins. Am J Hypertens 6 (1993) 72-75
19. Thibault C., and Anand-Srivastava M.B. Altered expression of G-protein mRNA in spontaneously hypertensive rats. FEBS Lett 313 (1992) 160-164
20. Lappas G., Daou G.B., and Anand-Srivastava M.B. Oxidative stress contributes to the enhanced expression of Giα proteins and adenylyl cyclase signaling in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 23 (2005) 2251-2261
21. Li Y., Lappas G., and Anand-Srivastava M.B. Role of oxidative stress in angiotensin II-induced enhanced expression of Gi(alpha) proteins and adenylyl cyclase signaling in A10 vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 292 (2007) H1922-H1930
22. Anand-Srivastava M.B. Downregulation of atrial natriuretic peptide ANP-C receptor is associated with alterations in G-protein expression in A10 smooth muscle cells. Biochemistry 39 (2000) 6503-6513
23. Touyz R.M., Chen X., Tabet F., Yao G., He G., Quinn M.T., et al. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin. Circ Res 90 (2002) 1205-1213
24. Abo A., Pick E., Hall A., Totty N., Teahan C.G., and Segal A.W. Activation of NADPH oxidase involves the small STP-binding protein p22 react. Nature 353 (1991) 668-670
25. Wu R., Millette E., Wu L., and de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J Hypertens 19 (2001) 741-748
26. Sanchez M., Galisteo M., Vera R., Villar I.C., Zarzuelo A., Tamargo J., et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 24 (2006) 75-84
27. Chabrashvili T., Tojo A., Onozato M.L., Kitiyakara C., Quinn M.T., Fujita T., et al. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39 (2002) 269-274
28. Paravicini T.M., Chrissobolis S., Drummond G.R., and Sobey C.G. Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo. Stroke 35 (2004) 584-589
29. Lodi F., Cogolludo A., Duarte J., Moreno L., Coviello A., Peral De Bruno M., et al. Increased NADPH oxidase activity mediates spontaneous aortic tone in genetically hypertensive rats. Eur J Pharmacol 544 (2006) 97-103
30. Zalba G., Beaumont F.J., San Jose G., Fortuno A., Fortuno M.A., Etayo J.C., et al. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35 (2000) 1055-1061
31. Virdis A., Fritsch Neves M., Amiri F., Viel E., Touyz R.M., and Schiffrin E.L. Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 40 (2002) 504-510
32. Li Y., and Anand-Srivastava M.B. Inactivation of enhanced expression of G(i) proteins by pertussis toxin attenuates the development of high blood pressure in spontaneously hypertensive rats. Circ Res 91 (2002) 247-254
33. Hector Polizio A., and Pena C. Effects of angiotensin II type 1 receptor blockade on the oxidative stress in spontaneously hypertensive rat tissues. Regul Pept 128 (2005) 1-5
34. Khattab M., Ahmad M., Al-Shabanah O.A., and Raza M. Effects of losartan on blood pressure, oxidative stress, and nitrate/nitrite levels in the nitric oxide deficient hypertensive rats. Receptors Channels 10 (2004) 147-157
35. Nishio M., Sakata Y., Mano T., Yoshida J., Ohtani T., Takeda Y., et al. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure. J Hypertens 25 (2007) 455-461
36. Izuhara Y., Nangaku M., Inagi R., Tominaga N., Aizawa T., Kurokawa K., et al. Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 16 (2005) 3631-3641
37. Marty C., Kozasa T., Quinn M.T., and Ye R.D. Activation state-dependent interaction between Giα and p67phox. Mol Cell Biol 13 (2006) 5190-5200